Sacubitril/valsartan alleviates myocardial fibrosis in diabetic cardiomyopathy rats

Código QR

Sacubitril/valsartan alleviates myocardial fibrosis in diabetic cardiomyopathy rats

Guardado en:

Detalles Bibliográficos
Autores principales:	Jiao Ai, Zhuang Shuai, Kai Tang, Zongyu Li, Luwei Zou, Mao Liu
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/618944e95eb9438cbbe6b146a4e04843
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Sacubitril/valsartan in real-life clinical practice
por: Yüksel Çavuşoğlu
Publicado: (2021)

Rationale for and Practical Use of Sacubitril/Valsartan in the Patient’s Journey with Heart Failure and Reduced Ejection Fraction
por: Mauro Gori, et al.
Publicado: (2021)

Prescription of Sacubitril/Valsartan in Patients with Heart Failure and Reduced Ejection Fraction Attending an Outpatient Heart Failure Clinic
por: M Rizzo, et al.
Publicado: (2020)

Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction
por: M Rizzo, et al.
Publicado: (2020)

The impact of discontinuation of sacubitril–valsartan and shifting to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with heart failure with reduced ejection fraction
por: Osama A. Amin, et al.
Publicado: (2021)

Angiotensin receptor-neprilysin inhibition by sacubitril/valsartan attenuates doxorubicin-induced cardiotoxicity in a pretreatment mice model by interfering with oxidative stress, inflammation, and Caspase 3 apoptotic pathway
por: Ferhat Dindaş, et al.
Publicado: (2021)

The effectiveness and tolerability of switching Indian patients from sacubitril/valsartan, ARNI to perindopril in heart failure with reduced ejection fraction. [Efficient study]
por: Pankaj Jariwala, et al.
Publicado: (2021)

Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review
por: Domingo Pascual-Figal, et al.
Publicado: (2021)

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Ryan Wallace, et al.
Publicado: (2021)

Time to reconsider risk stratification in dilated cardiomyopathy
por: A. Laina, et al.
Publicado: (2021)

Diabetic Cardiomyopathy: Five Major Questions with Simple Answers
por: Miguel Alejandro Rodriguez-Ramos
Publicado: (2019)

Arrhythmogenic Cardiomyopathy: A Disease or Merely a Phenotype?
por: Alexandros Protonotarios, et al.
Publicado: (2020)

Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden
por: J Gustav Smith, et al.
Publicado: (2021)

Restrictive cardiomyopathy with ring chromosome 6 anomaly in a child
por: Süleyman Sunkak, et al.
Publicado: (2021)

Myocardial fibrosis and its correlation with the predictors of morbidity and mortality in Eisenmenger syndrome
por: K. Divyashree, et al.
Publicado: (2021)

Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction
por: Nancy Luo, MD, MHS, et al.
Publicado: (2021)

Effects of SGLT-2 inhibitor on myocardial fibrosis and left ventricular reverse remodeling
por: Dipak Katare, et al.
Publicado: (2021)

Multimodality Imaging to Guide Ventricular Tachycardia Ablation in Patients with Non-ischaemic Cardiomyopathy
por: Ling Kuo, et al.
Publicado: (2020)

Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised Trials
por: Roland R Tilz, et al.
Publicado: (2019)

Dilated Cardiomyopathy Risk in Patients with Coronavirus Disease 2019: How to Identify and Characterise it Early?
por: Maki Komiyama, et al.
Publicado: (2020)

The Role of Cardiac MRI in the Management of Ventricular Arrhythmias in Ischaemic and Non-ischaemic Dilated Cardiomyopathy
por: Tom Nelson, et al.
Publicado: (2019)

From Hip to Heart: A Comprehensive Evaluation of an Infiltrative CardiomyopathyNovel Teaching Points
por: Manavotam Singh, MD, et al.
Publicado: (2021)

Myocardial mechanics in dilated cardiomyopathy: prognostic value of left ventricular torsion and strain
por: Andreas Ochs, et al.
Publicado: (2021)

Corrigendum to: Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised Trials
por: Roland R Tilz, et al.
Publicado: (2020)

Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA) in patients with hypertrophic cardiomyopathy
por: Sarinya Puwanant, et al.
Publicado: (2021)

Perioperative myocardial damage and the incidence of type 2 myocardial infarction in patients with intermediate and high cardiovascular risk
por: Miraç Vural Keskinler, et al.
Publicado: (2021)

Persistent left vertical vein: An unusual cause of pulmonary hypertension and cirrhosis in a patient with hypertrophic obstructive cardiomyopathy
por: Umut Karabulut, et al.
Publicado: (2021)

Mechanisms of Myocardial Injury in Coronavirus Disease 2019
por: Aniket S Rali, et al.
Publicado: (2020)

Is the increase in eltrombopag dose cause of myocardial infarction?
por: Edip Can Özgünoğlu, et al.
Publicado: (2021)

Early Death of 2 Siblings Related to Mutations in LMOD2, a Recently Discovered Cause of Neonatal Dilated Cardiomyopathy
por: Steven C. Greenway, MSc, MD, FRCPC, et al.
Publicado: (2021)

Severe right ventricular hypertrophy in hypertrophic cardiomyopathy: Serious symptoms, complex surgical procedures, and poor prognosis in Fuwai Hospital
por: Xueqi Dong, et al.
Publicado: (2021)

Myocardial and Microvascular Injury Due to Coronavirus Disease 2019
por: Rocco A Montone, et al.
Publicado: (2020)

Association of Hyperhomocysteinemia with Acute Myocardial Infarction in Iraqi Patients
por: S Othman Amen, et al.
Publicado: (2020)

Time for a new paradigm shift in myocardial infarction
por: Emre K. Aslanger, et al.
Publicado: (2021)

Atrial Fibrosis: Translational Considerations for the Management of AF Patients
por: Stylianos Tzeis, et al.
Publicado: (2019)

Association of Vitamin D Deficiency with Acute Myocardial Infarction in Iraqi Patients
por: S Othman Amen, et al.
Publicado: (2020)

You had a myocardial infarction. Time to find out more
por: Daniel Ferreira
Publicado: (2021)

Is myocardial bridge more frequently detected on radial access coronary angiography?
por: Oktay Şenöz, et al.
Publicado: (2021)

You had a myocardial infarction. Time to find out more
por: Daniel Ferreira
Publicado: (2021)

ECG and Pacing Criteria for Differentiating Conduction System Pacing from Myocardial Pacing
por: Marek Jastrzębski
Publicado: (2021)